1. Berberine Regulated Lipid Metabolism in the Presence of C75, Compound C, and TOFA in Breast Cancer Cell Line MCF-7
    Wen Tan et al, 2015, Evidence-Based Complementary and Alternative Medicine CrossRef
  2. Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells
    Yoshiaki Sunami et al, 2017, Cancers CrossRef
  3. Early Inhibition of Fatty Acid Synthesis Reduces Generation of Memory Precursor Effector T Cells in Chronic Infection
    Samad A. Ibitokou et al, 2018, J.I. CrossRef
  4. Lipid metabolism reprogramming and its potential targets in cancer.
    Chunming Cheng et al, 2018, Cancer Commun (Lond) CrossRef
  5. A Cellular Assay for Inhibitors of the Fatty Acid Biosynthetic Pathway Using Scintillating Microplates
    Thao Ung et al, 2015, ASSAY and Drug Development Technologies CrossRef
  6. Dropping in on lipid droplets: insights into cellular stress and cancer
    Peter Shyu et al, 2018, Biosci. Rep. CrossRef
  7. Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
    Hayato Nakagawa et al, 2018, Cancers CrossRef
  8. Lipid metabolic reprogramming in cancer cells
    S Beloribi-Djefaflia et al, 2016, Oncogenesis CrossRef
  9. null
    Maritza P. Garrido et al, 2019 CrossRef
  10. Metabolic Plasticity in Chemotherapy Resistance
    Maria Andrea Desbats et al, 2020, Front. Oncol. CrossRef
  11. Metabolomics profile in gastrointestinal cancers: Update and future perspectives
    Giulia Nannini et al, 2020, WJG CrossRef
  12. Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems
    Trenton T. Ross et al, 2020, Cellular and Molecular Gastroenterology and Hepatology CrossRef
  13. null
    Yoshiaki Sunami, 2020 CrossRef
  14. Targeting Lipid Metabolism in Liver Cancer.
    Malak Alannan et al, 2020, Biochemistry CrossRef
  15. Deregulation of Lipid Metabolism: The Critical Factors in Ovarian Cancer
    Zhaodong Ji et al, 2020, Front. Oncol. CrossRef
  16. Specific Effects of Trabectedin and Lurbinectedin on Human Macrophage Function and Fate—Novel Insights
    Adrián Povo-Retana et al, 2020, Cancers CrossRef
  17. Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment.
    Lara P Fernández et al, 2020, Front Oncol CrossRef
  18. Lipid Regulatory Proteins as Potential Therapeutic Targets for Ovarian Cancer in Obese Women.
    Jing Yang et al, 2020, Cancers (Basel) CrossRef
  19. Lipid metabolism in cancer progression and therapeutic strategies
    Yan Fu et al, 2020, MedComm CrossRef
  20. Lipid Metabolism in Oncology: Why It Matters, How to Research, and How to Treat
    Yuki Matsushita et al, 2021, Cancers CrossRef
  21. null
    Witchuda Sukjoi et al, 2021 CrossRef
  22. Lipid metabolism in cancer: A systematic review.
    Wafa Khan et al, 2021, J Carcinog CrossRef
  23. Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.
    Miljana Nenkov et al, 2021, Int J Mol Sci CrossRef
  24. Metabolic convergence on lipogenesis in RAS, BCR-ABL, and MYC-driven lymphoid malignancies
    Daniel F. Liefwalker et al, 2021, Cancer Metab CrossRef
  25. How cancer cells remodel lipid metabolism: strategies targeting transcription factors
    Do-Won Jeong et al, 2021, Lipids Health Dis CrossRef
  26. Too complex to fail? Targeting fatty acid metabolism for cancer therapy
    Rimsha Munir et al, 2021, Progress in Lipid Research CrossRef
  27. Lipogenesis inhibitors: therapeutic opportunities and challenges.
    Battsetseg Batchuluun et al, 2022, Nat Rev Drug Discov CrossRef
  28. Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer
    Kamal Eltayeb et al, 2022, Cells CrossRef
  29. The critical function of metabolic reprogramming in cancer metastasis
    Sun‐Zhe Xie et al, 2022, Aging and Cancer CrossRef
  30. Reprogramming of Fatty Acid Metabolism in Gynaecological Cancers: Is There a Role for Oestradiol?
    Azilleo Kristo Mozihim et al, 2022, Metabolites CrossRef
  31. null
    Satyendra Chandra Tripathi et al, 2022 CrossRef
  32. The Potential Role of Changes in the Glucose and Lipid Metabolic Pathways in Gastrointestinal Cancer Progression: Strategy in Cancer Therapy
    Gordon A. Ferns et al, 2021, Gastrointest Tumors CrossRef
  33. Effects of metabolic cancer therapy on tumor microenvironment
    Petra Hyroššová et al, 2022, Front. Oncol. CrossRef
  34. Progress of potential drugs targeted in lipid metabolism research
    Kai Liang et al, 2022, Front. Pharmacol. CrossRef
  35. Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability
    Daniel Thomas et al, 2023 CrossRef
  36. Physiological and pathological roles of lipogenesis
    Yong Geun Jeon et al, 2023, Nat Metab CrossRef
  37. Acetyl-CoA metabolism as a therapeutic target for cancer
    Guo Chen et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  38. Recent Advancements in Nanomedicine Based Lipid Metabolism for Tumor lmmunotherapy
    Yumeng Zhao et al, 2023, Journal of Drug Targeting CrossRef
  39. Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy
    Domiziana Masci et al, 2024, Molecules CrossRef